Switch to: References

Add citations

You must login to add citations.
  1. A "Queen of Hearts" trial of organ markets: why Scheper-Hughes's objections to markets in human organs fail.J. S. Taylor - 2007 - Journal of Medical Ethics 33 (4):201-204.
    Nancy Scheper-Hughes is one of the most prominent critics of markets in human organs. Unfortunately, Scheper-Hughes rejects the view that markets should be used to solve the current shortage of transplant organs without engaging with the arguments in favour of them. Scheper-Hughes’s rejection of such markets is of especial concern, given her influence over their future, for she holds, among other positions, the status of an adviser to the World Health Organization on issues related to global transplantation. Given her influence, (...)
    Download  
     
    Export citation  
     
    Bookmark   1 citation  
  • Assessing the Likely Harms to Kidney Vendors in Regulated Organ Markets.Julian Koplin - 2014 - American Journal of Bioethics 14 (10):7-18.
    Advocates of paid living kidney donation frequently argue that kidney sellers would benefit from paid donation under a properly regulated kidney market. The poor outcomes experienced by participants in existing markets are often entirely attributed to harmful black-market practices. This article reviews the medical and anthropological literature on the physical, psychological, social, and financial harms experienced by vendors under Iran's regulated system of donor compensation and black markets throughout the world and argues that this body of research not only documents (...)
    Download  
     
    Export citation  
     
    Bookmark   36 citations